Redefining BASDAI cut-offs in axial spondyloarthritis: implications for patients' eligibility for treatment with biologic disease-modifying antirheumatic drugs
Year: 2026
Type: article
Source: The Journal of Rheumatology
Authors: Stylianos Georgiadis, Lykke Midtbøll Ørnbjerg, Brigitte Michelsen, Tore K. Kvien, Mehrdad Shoae Kazemi, Kristýna Bubová, Heřman Mann, Karel Pavelka, Bente Glintborg, Anne Gitte Loft, Helena Santos, Andreas Reich, Anne C. Regierer, Jarno Rutanen, Laura Kuusalo, Gary J. Macfarlane, Gareth T. Jones, Adrian Ciurea, Michael J. Nissen, Bjorn Gudbjornsson, Ólafur Pálsson, Žiga Rotar, Katja Perdan Pirkmajer, Catalin Codreanu, Corina Mogosan, Sella Aarrestad Provan, Gunnstein Bakland, Daniela Di Giuseppe, Merete Lund Hetland, Mikkel Østergaard
Institutions: Glostrup Hospital, Rigshospitalet, Diakonhjemmet Hospital, Sørlandet Sykehus, University of Oslo, Charles University, Institute of Rheumatology, University of Copenhagen, Aarhus University, Aarhus University Hospital, Instituto Português de Reumatologia, Comprehensive Health Research Centre, German Rheumatism Research Centre, Tampere University Hospital, University of Turku, Turku University Hospital, University of Aberdeen, University of Zurich, University Hospital Zurich, University Hospital of Geneva, University of Iceland, National University Hospital of Iceland, Lund University, Skåne University Hospital, University of Ljubljana, Ljubljana University Medical Centre, Carol Davila University of Medicine and Pharmacy, University of Inland Norway, University Hospital of North Norway, UiT The Arctic University of Norway, Karolinska Institutet
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7233543267
FWCI:
Cites:
Cited by:
Related to:
